17 June 2021 : Clinical Research
Mid- and Long-Term Efficacy of Surgical Treatment of L1-2 Vertebral Tuberculosis with Subdiaphragmatic Extraperitoneal Approach
Fubiao Zhou1BEF, Qian Wang2CE, Liehua Liu1BC, Shuanqiang Han1B, Weidong Jin1DF, Zili Wang1ADFG*DOI: 10.12659/MSM.932284
Med Sci Monit 2021; 27:e932284
Table 1 General information of the 2 groups before surgery.
| Group A | Group B | P value | |
|---|---|---|---|
| Number of cases (cases) | 35 | 32 | – |
| Age | 45.66±16.69 | 46.06±16.84 | 0.922 |
| Male/Female (cases) | 21/14 | 19/13 | 0.958 |
| Clinical symptoms | |||
| Low back pain | 30 | 28 | 1.000 |
| Nerve damage | 16 | 15 | 0.924 |
| Low fever, night sweats | 17 | 14 | 0.693 |
| Fatigue | 21 | 17 | 0.570 |
| Cold abscess | 21 | 20 | 0.834 |
| Cobb angle (°) | 21.60±4.22 | 21.41±4.09 | 0.850 |
| ESR (mm/h) | 63.03±14.66 | 64.47±15.89 | 0.701 |
| CRP (mg/L) | 41.19±25.48 | 40.56±21.67 | 0.914 |
| VAS score | 5.49±1.93 | 5.63±1.86 | 0.765 |
| Group A: subdiaphragmatic extraperitoneal approach; Group B: thoracoabdominal approach. Values are presented as number or mean±standard deviation. ESR – erythrocyte sedimentation rate; CRP – C-reactive protein; VAS – visual analog scale. | |||